A phase 1 study of OSI-211 given as an intravenous infusion...

A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers

K. Gelmon, H. Hirte, B. Fisher, W. Walsh, M. Ptaszynski, M. Hamilton, N. Onetto, E. Eisenhauer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Pages:
13
DOI:
10.1023/b:drug.0000026252.86842.e2
Date:
August, 2004
File:
PDF, 283 KB
english, 2004
Conversion to is in progress
Conversion to is failed